| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
88,509 |
86,652 |
$11.83M |
| A4649 |
Surgical supply; miscellaneous |
2,948 |
2,603 |
$5.71M |
| J9271 |
Injection, pembrolizumab, 1 mg |
584 |
454 |
$4.98M |
| 0450 |
Emergency room services |
79,021 |
70,924 |
$4.56M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
44,269 |
43,453 |
$4.16M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
63,913 |
58,852 |
$3.93M |
| 70450 |
Computed tomography, head or brain; without contrast material |
11,411 |
11,092 |
$2.82M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
14,177 |
13,741 |
$2.55M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
12,946 |
12,449 |
$2.16M |
| 74178 |
|
6,217 |
6,092 |
$2.08M |
| 80053 |
Comprehensive metabolic panel |
102,919 |
86,772 |
$2.01M |
| 0510 |
|
43,082 |
35,542 |
$1.82M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
25,482 |
23,389 |
$1.76M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
50,771 |
46,378 |
$1.75M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
69,250 |
15,457 |
$1.68M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
108,265 |
82,133 |
$1.60M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
115,572 |
95,664 |
$1.58M |
| 99233 |
Prolong inpt eval add15 m |
20,425 |
8,701 |
$1.52M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
22,465 |
18,802 |
$1.21M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
25,215 |
20,145 |
$1.19M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
6,296 |
5,277 |
$1.13M |
| 99221 |
|
5,950 |
5,677 |
$1.11M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
17,710 |
12,239 |
$1.08M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
14,443 |
10,028 |
$953K |
| 99223 |
Prolong inpt eval add15 m |
8,323 |
8,046 |
$953K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,062 |
2,026 |
$938K |
| 0360 |
|
6,836 |
3,866 |
$916K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,757 |
2,709 |
$822K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
30,444 |
24,731 |
$696K |
| 99215 |
Prolong outpt/office vis |
7,850 |
6,749 |
$646K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
8,341 |
8,070 |
$642K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,555 |
14,094 |
$627K |
| L8699 |
Prosthetic implant, not otherwise specified |
153 |
151 |
$614K |
| J0897 |
Injection, denosumab, 1 mg |
629 |
621 |
$613K |
| 99499 |
|
3,405 |
2,817 |
$596K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
5,153 |
4,890 |
$594K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
5,938 |
5,727 |
$575K |
| 0361 |
|
3,039 |
2,546 |
$555K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
71,197 |
59,881 |
$535K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,217 |
2,175 |
$520K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
7,749 |
6,802 |
$516K |
| 84484 |
|
19,234 |
16,052 |
$513K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
8,817 |
4,413 |
$494K |
| 71045 |
Radiologic examination, chest; single view |
25,297 |
24,022 |
$437K |
| 71046 |
Radiologic examination, chest; 2 views |
14,774 |
14,380 |
$413K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
3,557 |
3,404 |
$371K |
| 83690 |
|
25,887 |
24,276 |
$362K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,682 |
4,424 |
$358K |
| 81001 |
|
53,011 |
48,955 |
$357K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
5,651 |
3,619 |
$351K |
| 72131 |
|
1,171 |
1,160 |
$338K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
7,108 |
6,594 |
$337K |
| 20610 |
|
11,461 |
8,515 |
$335K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
2,466 |
1,191 |
$326K |
| 93971 |
|
2,144 |
2,094 |
$325K |
| 84703 |
|
19,747 |
18,571 |
$319K |
| 0710 |
|
5,612 |
5,402 |
$317K |
| 99222 |
Initial hospital care, per day, moderate complexity |
2,848 |
2,720 |
$291K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
5,015 |
3,816 |
$291K |
| 76830 |
Ultrasound, transvaginal |
2,736 |
2,611 |
$285K |
| 97750 |
|
4,396 |
3,867 |
$282K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,803 |
4,705 |
$269K |
| 84702 |
|
10,832 |
9,705 |
$262K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
442 |
436 |
$248K |
| 73564 |
|
6,576 |
5,118 |
$247K |
| 73610 |
|
6,424 |
5,618 |
$246K |
| 73630 |
|
6,759 |
5,727 |
$242K |
| J3490 |
Unclassified drugs |
51,653 |
25,506 |
$233K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
675 |
669 |
$216K |
| Z7502 |
|
6,582 |
6,361 |
$211K |
| 73110 |
|
5,307 |
4,468 |
$208K |
| 0762 |
|
2,433 |
1,272 |
$201K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
5,743 |
3,421 |
$200K |
| 73030 |
|
5,852 |
5,246 |
$199K |
| 87631 |
|
2,473 |
2,449 |
$198K |
| S9976 |
Lodging, per diem, not otherwise classified |
3,757 |
1,734 |
$198K |
| 83735 |
|
19,141 |
14,158 |
$190K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,384 |
2,261 |
$165K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,384 |
2,260 |
$165K |
| 94799 |
|
1,920 |
1,599 |
$161K |
| 70486 |
|
525 |
518 |
$158K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
4,096 |
4,046 |
$158K |
| 99218 |
|
857 |
823 |
$157K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
14,980 |
14,469 |
$153K |
| 73130 |
|
3,987 |
3,455 |
$153K |
| 70496 |
|
696 |
691 |
$152K |
| 87507 |
|
403 |
394 |
$152K |
| 74174 |
|
491 |
488 |
$147K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
10,172 |
9,250 |
$145K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,021 |
5,637 |
$143K |
| 87040 |
|
7,459 |
4,112 |
$143K |
| 82947 |
|
17,626 |
10,744 |
$142K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
6,128 |
5,395 |
$140K |
| 93976 |
|
422 |
407 |
$139K |
| 96367 |
|
3,307 |
2,467 |
$134K |
| 71250 |
|
529 |
525 |
$134K |
| 70498 |
|
786 |
782 |
$130K |
| 83880 |
|
5,198 |
4,827 |
$128K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,026 |
1,015 |
$128K |
| 97799 |
|
4,194 |
1,550 |
$125K |
| 83605 |
|
6,240 |
5,492 |
$124K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
11,478 |
10,878 |
$124K |
| 88304 |
|
2,320 |
2,154 |
$120K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,958 |
1,832 |
$119K |
| 73562 |
|
3,762 |
3,451 |
$117K |
| 76801 |
|
1,357 |
1,218 |
$116K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
203 |
133 |
$108K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,686 |
1,659 |
$106K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
419 |
409 |
$106K |
| 0272 |
|
798 |
733 |
$105K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,309 |
2,287 |
$102K |
| 97763 |
|
2,393 |
990 |
$102K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
494 |
418 |
$102K |
| 86850 |
|
7,370 |
6,705 |
$101K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,114 |
1,009 |
$99K |
| 88342 |
|
1,219 |
1,000 |
$97K |
| 86923 |
|
806 |
487 |
$96K |
| 73502 |
|
2,749 |
2,683 |
$93K |
| 85730 |
|
9,723 |
8,960 |
$92K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
1,187 |
691 |
$89K |
| 97139 |
|
3,431 |
588 |
$85K |
| 72110 |
|
1,250 |
1,221 |
$85K |
| 94664 |
|
5,689 |
4,778 |
$84K |
| 99070 |
|
3,786 |
2,540 |
$83K |
| 85610 |
|
17,041 |
13,461 |
$82K |
| 87081 |
|
7,154 |
7,045 |
$78K |
| 36415 |
Collection of venous blood by venipuncture |
21,420 |
16,573 |
$76K |
| 93308 |
|
561 |
555 |
$74K |
| 87186 |
|
4,927 |
4,210 |
$73K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
7,160 |
2,703 |
$71K |
| J2785 |
Injection, regadenoson, 0.1 mg |
950 |
943 |
$71K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
8,011 |
7,226 |
$69K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
255 |
134 |
$69K |
| 71270 |
|
203 |
202 |
$66K |
| 72100 |
|
1,553 |
1,527 |
$65K |
| G0378 |
Hospital observation service, per hour |
1,371 |
992 |
$59K |
| 93970 |
|
224 |
221 |
$58K |
| 62323 |
|
739 |
730 |
$57K |
| 87641 |
|
1,833 |
1,807 |
$57K |
| 96415 |
|
2,063 |
1,373 |
$57K |
| 72128 |
|
230 |
229 |
$57K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
31 |
24 |
$56K |
| 86901 |
|
7,339 |
6,677 |
$56K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,148 |
5,057 |
$56K |
| 81025 |
|
6,278 |
6,023 |
$56K |
| J8501 |
Aprepitant, oral, 5 mg |
1,411 |
1,381 |
$55K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
4,774 |
4,430 |
$54K |
| 73140 |
|
2,067 |
1,847 |
$54K |
| 86140 |
|
6,084 |
5,682 |
$52K |
| 87070 |
|
3,036 |
2,903 |
$52K |
| 96523 |
|
1,254 |
898 |
$51K |
| 64450 |
|
704 |
687 |
$50K |
| 73070 |
|
1,473 |
1,233 |
$49K |
| 97165 |
|
1,030 |
958 |
$48K |
| 0637 |
|
3,414 |
2,164 |
$47K |
| 87077 |
|
6,511 |
5,220 |
$47K |
| 94060 |
|
1,202 |
1,166 |
$47K |
| J1815 |
Injection, insulin, per 5 units |
2,324 |
1,640 |
$46K |
| 76870 |
|
434 |
414 |
$46K |
| 90715 |
|
1,485 |
1,458 |
$45K |
| J1756 |
Injection, iron sucrose, 1 mg |
1,852 |
877 |
$44K |
| Q3014 |
Telehealth originating site facility fee |
5,477 |
4,912 |
$43K |
| 99217 |
|
687 |
682 |
$43K |
| 85379 |
|
1,954 |
1,928 |
$42K |
| 27447 |
|
53 |
51 |
$41K |
| 73590 |
|
1,213 |
1,101 |
$40K |
| J1437 |
Injection, ferric derisomaltose, 10 mg |
27 |
27 |
$40K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
688 |
683 |
$40K |
| 86900 |
|
7,349 |
6,689 |
$38K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
11,044 |
9,739 |
$37K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,987 |
1,933 |
$37K |
| 73080 |
|
909 |
852 |
$37K |
| 64483 |
|
991 |
980 |
$36K |
| J2704 |
Injection, propofol, 10 mg |
11,841 |
11,243 |
$35K |
| 82550 |
|
2,927 |
2,666 |
$35K |
| 96417 |
|
985 |
606 |
$34K |
| 87075 |
|
1,960 |
1,789 |
$33K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
565 |
279 |
$32K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,010 |
2,890 |
$32K |
| 49083 |
|
485 |
288 |
$31K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
19,657 |
18,294 |
$30K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
8,169 |
6,513 |
$29K |
| 94729 |
|
934 |
915 |
$29K |
| 73560 |
|
1,087 |
986 |
$29K |
| 73090 |
|
834 |
702 |
$29K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
18,273 |
15,461 |
$29K |
| 99224 |
|
338 |
323 |
$28K |
| 84439 |
|
2,285 |
2,053 |
$26K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
3,160 |
2,862 |
$26K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
7,438 |
6,452 |
$26K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
8,072 |
7,268 |
$26K |
| 64493 |
|
576 |
561 |
$25K |
| J7050 |
Infusion, normal saline solution, 250 cc |
18,646 |
9,139 |
$25K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
10,655 |
6,308 |
$25K |
| 88313 |
|
418 |
271 |
$25K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
194 |
193 |
$24K |
| 0100U |
|
184 |
177 |
$24K |
| 87205 |
|
3,232 |
2,917 |
$23K |
| 77002 |
|
625 |
613 |
$23K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
23,581 |
20,594 |
$23K |
| 84100 |
|
4,190 |
3,297 |
$23K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
342 |
335 |
$22K |
| 94726 |
|
762 |
749 |
$22K |
| 80061 |
Lipid panel |
3,054 |
2,986 |
$21K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
4,037 |
3,842 |
$20K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
199 |
195 |
$20K |
| 97162 |
|
1,087 |
1,076 |
$19K |
| 20550 |
|
1,348 |
1,126 |
$19K |
| 99454 |
|
1,813 |
1,812 |
$19K |
| C9088 |
Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg |
64 |
62 |
$19K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,701 |
1,711 |
$19K |
| 81003 |
|
5,514 |
5,116 |
$18K |
| 74018 |
|
666 |
632 |
$18K |
| 72170 |
|
499 |
492 |
$18K |
| 99443 |
|
291 |
277 |
$18K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
6,873 |
5,512 |
$18K |
| 93017 |
|
347 |
340 |
$18K |
| 96368 |
|
849 |
630 |
$17K |
| 82805 |
|
322 |
302 |
$17K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
4,122 |
2,080 |
$17K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
2,544 |
2,439 |
$17K |
| 85652 |
|
4,350 |
4,043 |
$16K |
| 70492 |
|
55 |
54 |
$16K |
| 88307 |
|
171 |
157 |
$16K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
811 |
809 |
$15K |
| 94760 |
|
3,178 |
2,641 |
$15K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
4,441 |
4,282 |
$15K |
| 76604 |
|
362 |
350 |
$15K |
| 82728 |
|
2,132 |
2,062 |
$15K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
325 |
152 |
$15K |
| 0250 |
|
534 |
453 |
$15K |
| 72040 |
|
361 |
344 |
$15K |
| 82607 |
|
2,056 |
2,024 |
$14K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
10,966 |
9,850 |
$14K |
| 84145 |
|
653 |
640 |
$14K |
| 64494 |
|
520 |
507 |
$14K |
| 77065 |
Tomosynthesis, mammo |
214 |
204 |
$13K |
| 99225 |
|
156 |
151 |
$13K |
| C9145 |
Injection, aprepitant, (aponvie), 1 mg |
275 |
273 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,336 |
1,222 |
$13K |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
3,121 |
2,738 |
$13K |
| 70488 |
|
39 |
38 |
$13K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
7,863 |
7,543 |
$12K |
| 82746 |
|
1,190 |
1,172 |
$12K |
| 74240 |
|
111 |
109 |
$12K |
| 29405 |
|
517 |
405 |
$12K |
| 88311 |
|
772 |
737 |
$11K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
76 |
72 |
$11K |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
350 |
290 |
$11K |
| 59025 |
Fetal non-stress test |
467 |
422 |
$11K |
| 73000 |
|
290 |
250 |
$11K |
| 87071 |
|
1,868 |
1,756 |
$10K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,197 |
1,177 |
$10K |
| 93880 |
|
136 |
135 |
$10K |
| 77066 |
Tomosynthesis, mammo |
130 |
125 |
$10K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,941 |
1,555 |
$10K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
620 |
380 |
$10K |
| 76642 |
|
163 |
159 |
$10K |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
4,414 |
2,120 |
$10K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,156 |
1,135 |
$10K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,586 |
1,369 |
$9K |
| 86803 |
|
452 |
451 |
$9K |
| J1453 |
Injection, fosaprepitant, 1 mg |
322 |
224 |
$9K |
| 74241 |
|
85 |
84 |
$9K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
5,365 |
4,919 |
$8K |
| J7327 |
Hyaluronan or derivative, monovisc, for intra-articular injection, per dose |
12 |
12 |
$8K |
| 82010 |
|
504 |
469 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,835 |
1,762 |
$8K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,757 |
851 |
$8K |
| 87088 |
|
791 |
743 |
$8K |
| 82248 |
|
870 |
854 |
$8K |
| 29125 |
|
542 |
506 |
$8K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,524 |
1,857 |
$8K |
| 96376 |
|
889 |
671 |
$8K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,187 |
1,091 |
$8K |
| 73700 |
|
26 |
26 |
$7K |
| 82375 |
|
331 |
313 |
$7K |
| 83550 |
|
1,691 |
1,643 |
$7K |
| 73100 |
|
240 |
174 |
$7K |
| 87340 |
|
559 |
557 |
$7K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
236 |
201 |
$7K |
| 51798 |
|
393 |
366 |
$7K |
| 97116 |
|
1,003 |
592 |
$6K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
885 |
861 |
$6K |
| 76770 |
|
62 |
62 |
$6K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
987 |
829 |
$6K |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
548 |
529 |
$6K |
| 20611 |
|
247 |
185 |
$6K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
9,761 |
9,469 |
$6K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
6,016 |
4,562 |
$6K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
2,507 |
2,281 |
$5K |
| 99457 |
|
698 |
696 |
$5K |
| 86706 |
|
329 |
329 |
$5K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,318 |
1,441 |
$5K |
| C1769 |
Guide wire |
64 |
55 |
$5K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,827 |
1,688 |
$5K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
1,033 |
688 |
$5K |
| 26055 |
|
32 |
24 |
$5K |
| 76942 |
|
136 |
107 |
$5K |
| 99442 |
|
109 |
106 |
$5K |
| 29881 |
|
24 |
24 |
$4K |
| 86780 |
|
312 |
286 |
$4K |
| 88300 |
|
201 |
188 |
$4K |
| 29075 |
|
313 |
286 |
$4K |
| 87428 |
|
592 |
579 |
$4K |
| 87807 |
|
379 |
363 |
$4K |
| 83050 |
|
319 |
301 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
123 |
120 |
$4K |
| 82570 |
|
1,074 |
936 |
$4K |
| J2060 |
Injection, lorazepam, 2 mg |
3,152 |
2,657 |
$4K |
| 29515 |
|
301 |
245 |
$4K |
| 64635 |
|
39 |
39 |
$4K |
| 87147 |
|
450 |
399 |
$4K |
| 90837 |
Psychotherapy, 53 minutes with patient |
245 |
149 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
906 |
843 |
$3K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
170 |
170 |
$3K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
12 |
12 |
$3K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
6,416 |
6,318 |
$3K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,388 |
892 |
$3K |
| 83615 |
|
954 |
863 |
$3K |
| 64488 |
|
59 |
36 |
$3K |
| 51701 |
|
47 |
47 |
$3K |
| 64636 |
|
54 |
50 |
$3K |
| 29827 |
|
12 |
12 |
$3K |
| J7318 |
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg |
12 |
12 |
$3K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
4,732 |
4,142 |
$3K |
| 88341 |
|
36 |
26 |
$3K |
| 88112 |
|
77 |
66 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
224 |
175 |
$3K |
| 93296 |
|
264 |
263 |
$3K |
| 84132 |
|
61 |
60 |
$3K |
| 86704 |
|
155 |
155 |
$3K |
| 20526 |
|
240 |
237 |
$3K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
284 |
274 |
$3K |
| 87210 |
|
285 |
281 |
$3K |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,972 |
1,127 |
$3K |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
492 |
485 |
$2K |
| 96416 |
|
40 |
25 |
$2K |
| 86308 |
|
231 |
228 |
$2K |
| 12001 |
|
142 |
138 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
37 |
37 |
$2K |
| 01400 |
|
13 |
13 |
$2K |
| 10060 |
|
98 |
92 |
$2K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
50 |
50 |
$2K |
| 86592 |
|
355 |
342 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
28 |
24 |
$2K |
| 71101 |
|
24 |
24 |
$2K |
| 20605 |
|
50 |
48 |
$2K |
| 84550 |
|
372 |
319 |
$2K |
| 96521 |
|
92 |
24 |
$2K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
80 |
25 |
$2K |
| 99497 |
|
32 |
28 |
$2K |
| 51702 |
|
73 |
64 |
$2K |
| 0097U |
|
13 |
13 |
$1K |
| 84156 |
|
431 |
330 |
$1K |
| 76376 |
|
286 |
284 |
$1K |
| 76937 |
|
29 |
28 |
$1K |
| 29848 |
|
13 |
13 |
$1K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
249 |
204 |
$1K |
| 99024 |
|
436 |
363 |
$1K |
| 64490 |
|
24 |
24 |
$1K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
36 |
25 |
$1K |
| J9190 |
Injection, fluorouracil, 500 mg |
181 |
41 |
$1K |
| 99152 |
|
68 |
61 |
$1K |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
510 |
491 |
$1K |
| 62321 |
|
39 |
39 |
$1K |
| 73521 |
|
50 |
49 |
$1K |
| 83970 |
|
27 |
27 |
$1K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
2,421 |
1,979 |
$1K |
| 76882 |
|
38 |
37 |
$1K |
| 82272 |
|
395 |
378 |
$980.08 |
| 90686 |
|
184 |
184 |
$959.26 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
416 |
351 |
$883.49 |
| 97166 |
|
40 |
40 |
$861.76 |
| 73503 |
|
22 |
22 |
$810.30 |
| 99219 |
|
14 |
14 |
$780.00 |
| 88302 |
|
13 |
12 |
$767.99 |
| J3411 |
Injection, thiamine hcl, 100 mg |
208 |
166 |
$739.98 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
269 |
241 |
$734.49 |
| 96402 |
|
55 |
50 |
$730.56 |
| 73552 |
|
29 |
29 |
$710.80 |
| 97535 |
Self-care/home management training, each 15 minutes |
117 |
63 |
$710.38 |
| 87015 |
|
60 |
56 |
$671.44 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
41 |
41 |
$655.40 |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
60 |
55 |
$597.97 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$577.72 |
| 12011 |
|
25 |
24 |
$549.21 |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
179 |
175 |
$545.91 |
| 25600 |
|
27 |
24 |
$537.65 |
| 93356 |
|
25 |
25 |
$532.68 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,195 |
1,018 |
$521.83 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
191 |
169 |
$516.37 |
| 84300 |
|
98 |
89 |
$501.72 |
| 80320 |
|
385 |
361 |
$490.26 |
| 97014 |
|
148 |
52 |
$481.48 |
| 86709 |
|
25 |
25 |
$472.00 |
| 85027 |
|
47 |
39 |
$464.50 |
| J1940 |
Injection, furosemide, up to 20 mg |
526 |
354 |
$453.75 |
| 97163 |
|
16 |
16 |
$442.69 |
| J1953 |
Injection, levetiracetam, 10 mg |
76 |
66 |
$399.70 |
| 29065 |
|
19 |
16 |
$399.01 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
127 |
95 |
$362.78 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
109 |
108 |
$347.25 |
| 64484 |
|
48 |
48 |
$333.20 |
| J1790 |
Injection, droperidol, up to 5 mg |
29 |
26 |
$306.82 |
| 87106 |
|
14 |
13 |
$305.22 |
| J3360 |
Injection, diazepam, up to 5 mg |
45 |
45 |
$298.87 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
64 |
64 |
$288.94 |
| 99195 |
|
12 |
12 |
$273.39 |
| 86880 |
|
36 |
28 |
$257.07 |
| 82378 |
|
12 |
12 |
$251.40 |
| C9113 |
Injection, pantoprazole sodium, per vial |
54 |
38 |
$231.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
30 |
29 |
$225.90 |
| 99458 |
|
12 |
12 |
$225.49 |
| 83520 |
|
27 |
25 |
$225.20 |
| 84403 |
|
29 |
29 |
$205.59 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
45 |
27 |
$205.54 |
| 84165 |
|
25 |
25 |
$193.55 |
| 97161 |
|
13 |
13 |
$189.36 |
| J1956 |
Injection, levofloxacin, 250 mg |
107 |
94 |
$171.15 |
| 89051 |
|
15 |
14 |
$152.80 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
232 |
231 |
$151.68 |
| 82784 |
|
32 |
24 |
$138.55 |
| 82043 |
|
164 |
160 |
$128.56 |
| 0003A |
|
12 |
12 |
$120.00 |
| 96401 |
|
30 |
12 |
$119.38 |
| J0737 |
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg |
14 |
12 |
$118.82 |
| 29085 |
|
14 |
12 |
$117.60 |
| 0451 |
|
801 |
768 |
$114.85 |
| J0280 |
Injection, aminophyllin, up to 250 mg |
26 |
26 |
$113.40 |
| 84153 |
|
12 |
12 |
$112.72 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
130 |
105 |
$100.15 |
| 20552 |
|
12 |
12 |
$98.69 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
132 |
120 |
$91.96 |
| 64615 |
|
13 |
12 |
$91.01 |
| 64491 |
|
12 |
12 |
$88.20 |
| G0008 |
Administration of influenza virus vaccine |
311 |
311 |
$77.55 |
| J1630 |
Injection, haloperidol, up to 5 mg |
54 |
50 |
$71.28 |
| J0290 |
Injection, ampicillin sodium, 500 mg |
41 |
41 |
$51.31 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
23 |
12 |
$43.70 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
37 |
35 |
$34.10 |
| 90653 |
|
28 |
28 |
$33.57 |
| 99453 |
|
26 |
26 |
$24.88 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
50 |
50 |
$24.45 |
| 85045 |
|
12 |
12 |
$19.72 |
| 86359 |
|
12 |
12 |
$19.57 |
| 86360 |
|
12 |
12 |
$17.77 |
| J1836 |
Injection, metronidazole, 10 mg |
17 |
13 |
$17.00 |
| 87185 |
|
14 |
12 |
$13.16 |
| J7510 |
Prednisolone oral, per 5 mg |
25 |
25 |
$6.78 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
27 |
25 |
$3.30 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
102 |
85 |
$0.01 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
86 |
73 |
$0.01 |
| 91300 |
|
66 |
65 |
$0.00 |
| 0002A |
|
30 |
29 |
$0.00 |
| 1160F |
|
13 |
12 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
14 |
13 |
$0.00 |
| 3288F |
|
13 |
12 |
$0.00 |
| 94761 |
|
12 |
12 |
$0.00 |
| 90694 |
|
92 |
92 |
$0.00 |
| 3008F |
|
13 |
12 |
$0.00 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
62 |
61 |
$0.00 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
14 |
13 |
$0.00 |
| 0001A |
|
28 |
28 |
$0.00 |
| 1170F |
|
13 |
12 |
$0.00 |
| 80329 |
|
100 |
48 |
$0.00 |
| 0270 |
|
17 |
13 |
$0.00 |
| Q4051 |
Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) |
17 |
17 |
$0.00 |